Published in Biometrics on September 01, 1988
Macular Ganglion Cell Analysis (GCA) of the Cirrus HD-OCT in Glaucoma | NCT01272102
FastTree 2--approximately maximum-likelihood trees for large alignments. PLoS One (2010) 26.15
pROC: an open-source package for R and S+ to analyze and compare ROC curves. BMC Bioinformatics (2011) 16.75
FastTree: computing large minimum evolution trees with profiles instead of a distance matrix. Mol Biol Evol (2009) 15.15
Combined screening with ultrasound and mammography vs mammography alone in women at elevated risk of breast cancer. JAMA (2008) 10.92
Genotype score in addition to common risk factors for prediction of type 2 diabetes. N Engl J Med (2008) 9.68
Low diagnostic yield of elective coronary angiography. N Engl J Med (2010) 9.38
Diagnostic accuracy of fractional flow reserve from anatomic CT angiography. JAMA (2012) 6.96
Comparison of novel risk markers for improvement in cardiovascular risk assessment in intermediate-risk individuals. JAMA (2012) 6.29
Validation of screening questions for limited health literacy in a large VA outpatient population. J Gen Intern Med (2008) 6.10
Sensitivity and specificity of a single emergency department measurement of urinary neutrophil gelatinase-associated lipocalin for diagnosing acute kidney injury. Ann Intern Med (2008) 5.89
Diagnostic accuracy of digital versus film mammography: exploratory analysis of selected population subgroups in DMIST. Radiology (2008) 5.59
Genic intolerance to functional variation and the interpretation of personal genomes. PLoS Genet (2013) 5.58
Risk Algorithm Using Serial Biomarker Measurements Doubles the Number of Screen-Detected Cancers Compared With a Single-Threshold Rule in the United Kingdom Collaborative Trial of Ovarian Cancer Screening. J Clin Oncol (2015) 5.37
Text categorization models for high-quality article retrieval in internal medicine. J Am Med Inform Assoc (2004) 5.35
Glypican-1 identifies cancer exosomes and detects early pancreatic cancer. Nature (2015) 5.15
Using clinical factors and mammographic breast density to estimate breast cancer risk: development and validation of a new predictive model. Ann Intern Med (2008) 4.81
A novel method for accurate operon predictions in all sequenced prokaryotes. Nucleic Acids Res (2005) 4.68
Coronary computed tomography angiography for early triage of patients with acute chest pain: the ROMICAT (Rule Out Myocardial Infarction using Computer Assisted Tomography) trial. J Am Coll Cardiol (2009) 4.54
Detection of macular ganglion cell loss in glaucoma by Fourier-domain optical coherence tomography. Ophthalmology (2009) 4.44
Prostate specific antigen concentration at age 60 and death or metastasis from prostate cancer: case-control study. BMJ (2010) 4.42
Pulmonary hypertension in heart failure with preserved ejection fraction: a community-based study. J Am Coll Cardiol (2009) 4.16
Reducing unnecessary biopsy during prostate cancer screening using a four-kallikrein panel: an independent replication. J Clin Oncol (2010) 4.15
A strategy for predicting the chemosensitivity of human cancers and its application to drug discovery. Proc Natl Acad Sci U S A (2007) 3.78
Can urinary PCA3 supplement PSA in the early detection of prostate cancer? J Clin Oncol (2014) 3.64
Contributions of symptoms, signs, erythrocyte sedimentation rate, and C-reactive protein to a diagnosis of pneumonia in acute lower respiratory tract infection. Br J Gen Pract (2003) 3.56
Postoperative biomarkers predict acute kidney injury and poor outcomes after adult cardiac surgery. J Am Soc Nephrol (2011) 3.53
Performance of pharmacovigilance signal-detection algorithms for the FDA adverse event reporting system. Clin Pharmacol Ther (2013) 3.44
A comparison of prediction models for fractures in older women: is more better? Arch Intern Med (2009) 3.37
Development and validation of a biomarker for diarrhea-predominant irritable bowel syndrome in human subjects. PLoS One (2015) 3.37
Locally advanced breast cancer: MR imaging for prediction of response to neoadjuvant chemotherapy--results from ACRIN 6657/I-SPY TRIAL. Radiology (2012) 3.36
A first-generation multiplex biomarker analysis of urine for the early detection of prostate cancer. Cancer Res (2008) 3.35
Selection of target sites for mobile DNA integration in the human genome. PLoS Comput Biol (2006) 3.21
Temporal relationship and predictive value of urinary acute kidney injury biomarkers after pediatric cardiopulmonary bypass. J Am Coll Cardiol (2011) 3.17
Urinary cystatin C as an early biomarker of acute kidney injury following adult cardiothoracic surgery. Kidney Int (2008) 3.12
Elevation of circulating branched-chain amino acids is an early event in human pancreatic adenocarcinoma development. Nat Med (2014) 3.09
Inflammatory and metabolic biomarkers and risk of liver and biliary tract cancer. Hepatology (2014) 3.06
Improved performance of urinary biomarkers of acute kidney injury in the critically ill by stratification for injury duration and baseline renal function. Kidney Int (2011) 3.05
Urinary biomarkers in the clinical prognosis and early detection of acute kidney injury. Clin J Am Soc Nephrol (2010) 3.03
A framework for evaluating biomarkers for early detection: validation of biomarker panels for ovarian cancer. Cancer Prev Res (Phila) (2011) 3.03
Glucose variability and mortality in patients with sepsis. Crit Care Med (2008) 3.00
Hepatic dysfunction in ambulatory patients with heart failure: application of the MELD scoring system for outcome prediction. J Am Coll Cardiol (2013) 3.00
B-type natriuretic peptides and mortality after stroke: a systematic review and meta-analysis. Neurology (2013) 2.98
Integration of genetic risk factors into a clinical algorithm for multiple sclerosis susceptibility: a weighted genetic risk score. Lancet Neurol (2009) 2.95
Urinary neutrophil gelatinase-associated lipocalin distinguishes pre-renal from intrinsic renal failure and predicts outcomes. Kidney Int (2011) 2.94
Prospective validation of a 1-hour algorithm to rule-out and rule-in acute myocardial infarction using a high-sensitivity cardiac troponin T assay. CMAJ (2015) 2.88
High-risk plaque detected on coronary CT angiography predicts acute coronary syndromes independent of significant stenosis in acute chest pain: results from the ROMICAT-II trial. J Am Coll Cardiol (2014) 2.86
Derivation and validation of diagnostic thresholds for central blood pressure measurements based on long-term cardiovascular risks. J Am Coll Cardiol (2013) 2.79
Mapping of macular substructures with optical coherence tomography for glaucoma diagnosis. Ophthalmology (2007) 2.77
Surgical ineligibility and mortality among patients with unprotected left main or multivessel coronary artery disease undergoing percutaneous coronary intervention. Circulation (2014) 2.74
Different regional patterns of cortical thinning in Alzheimer's disease and frontotemporal dementia. Brain (2007) 2.72
Replication of TPMT and ABCC3 genetic variants highly associated with cisplatin-induced hearing loss in children. Clin Pharmacol Ther (2013) 2.70
Urinary TMPRSS2:ERG and PCA3 in an active surveillance cohort: results from a baseline analysis in the Canary Prostate Active Surveillance Study. Clin Cancer Res (2013) 2.70
Receiver operating characteristic (ROC) curve: practical review for radiologists. Korean J Radiol (2004) 2.69
The prostate health index selectively identifies clinically significant prostate cancer. J Urol (2014) 2.68
Identification of serum metabolites associated with risk of type 2 diabetes using a targeted metabolomic approach. Diabetes (2012) 2.62
Testing for improvement in prediction model performance. Stat Med (2013) 2.62
Urine TMPRSS2:ERG fusion transcript stratifies prostate cancer risk in men with elevated serum PSA. Sci Transl Med (2011) 2.62
Replication and extension of genome-wide association study results for obesity in 4923 adults from northern Sweden. Hum Mol Genet (2009) 2.58
Analysis of fecal DNA methylation to detect gastrointestinal neoplasia. J Natl Cancer Inst (2009) 2.57
Relation of central adiposity and body mass index to the development of diabetes in the Diabetes Prevention Program. Am J Clin Nutr (2008) 2.55
Prospective evaluation of operating characteristics of prostate cancer detection biomarkers. J Urol (2010) 2.54
Polygenic type 2 diabetes prediction at the limit of common variant detection. Diabetes (2014) 2.52
Early diagnosis of Alzheimer's disease using cortical thickness: impact of cognitive reserve. Brain (2009) 2.51
Estimating activity and sedentary behavior from an accelerometer on the hip or wrist. Med Sci Sports Exerc (2013) 2.48
Parental history of myopia, sports and outdoor activities, and future myopia. Invest Ophthalmol Vis Sci (2007) 2.45
Functional Status Scale: new pediatric outcome measure. Pediatrics (2009) 2.42
Using sensation seeking to target adolescents for substance use interventions. Addiction (2010) 2.41
Gene-expression signature of vascular invasion in hepatocellular carcinoma. J Hepatol (2011) 2.39
Non-contrast T1-mapping detects acute myocardial edema with high diagnostic accuracy: a comparison to T2-weighted cardiovascular magnetic resonance. J Cardiovasc Magn Reson (2012) 2.34
Potential impact of adding genetic markers to clinical parameters in predicting prostate biopsy outcomes in men following an initial negative biopsy: findings from the REDUCE trial. Eur Urol (2012) 2.34
Incident heart failure prediction in the elderly: the health ABC heart failure score. Circ Heart Fail (2008) 2.33
Validation of the Infectious Disease Society of America/American Thoracic Society 2007 guidelines for severe community-acquired pneumonia. Crit Care Med (2009) 2.32
Angiopoietin-2 may contribute to multiple organ dysfunction and death in sepsis*. Crit Care Med (2012) 2.32
Impact of cryopreservation on tetramer, cytokine flow cytometry, and ELISPOT. BMC Immunol (2005) 2.31
A mouse to human search for plasma proteome changes associated with pancreatic tumor development. PLoS Med (2008) 2.31
Comparison of fully automated computer analysis and visual scoring for detection of coronary artery disease from myocardial perfusion SPECT in a large population. J Nucl Med (2013) 2.30
A modified sequential organ failure assessment score for critical care triage. Disaster Med Public Health Prep (2010) 2.28
Minimally elevated cardiac troponin T and elevated N-terminal pro-B-type natriuretic peptide predict mortality in older adults: results from the Rancho Bernardo Study. J Am Coll Cardiol (2008) 2.26
Utility of a new model to diagnose an alcohol basis for steatohepatitis. Gastroenterology (2006) 2.25
One statistical test is sufficient for assessing new predictive markers. BMC Med Res Methodol (2011) 2.24
Simultaneous Prediction of New Morbidity, Mortality, and Survival Without New Morbidity From Pediatric Intensive Care: A New Paradigm for Outcomes Assessment. Crit Care Med (2015) 2.24
Using the optimal receiver operating characteristic curve to design a predictive genetic test, exemplified with type 2 diabetes. Am J Hum Genet (2008) 2.20
Prediction of chronic obstructive pulmonary disease (COPD) in asthma patients using electronic medical records. J Am Med Inform Assoc (2009) 2.20
Systemic complement activation in age-related macular degeneration. PLoS One (2008) 2.18
A comparison of denominator degrees of freedom methods for multiple observer ROC analysis. Stat Med (2007) 2.13
Comprehensive comparison of self-administered questionnaires for measuring quantitative autistic traits in adults. J Autism Dev Disord (2014) 2.13
Use of the nicotine metabolite ratio as a genetically informed biomarker of response to nicotine patch or varenicline for smoking cessation: a randomised, double-blind placebo-controlled trial. Lancet Respir Med (2015) 2.12
Serum procalcitonin and C-reactive protein concentrations to distinguish mildly infected from non-infected diabetic foot ulcers: a pilot study. Diabetologia (2007) 2.12
Circulating tumor DNA as an early marker of therapeutic response in patients with metastatic colorectal cancer. Ann Oncol (2015) 2.12
Integration of early physiological responses predicts later illness severity in preterm infants. Sci Transl Med (2010) 2.12
Association of CMR-measured LA function with heart failure development: results from the MESA study. JACC Cardiovasc Imaging (2014) 2.11
The human gut microbiome as a screening tool for colorectal cancer. Cancer Prev Res (Phila) (2014) 2.08
Devices for rapid diagnosis of Malaria: evaluation of prototype assays that detect Plasmodium falciparum histidine-rich protein 2 and a Plasmodium vivax-specific antigen. J Clin Microbiol (2003) 2.08
A 15-Year Warranty Period for Asymptomatic Individuals Without Coronary Artery Calcium: A Prospective Follow-Up of 9,715 Individuals. JACC Cardiovasc Imaging (2015) 2.08
Estimation and Comparison of Receiver Operating Characteristic Curves. Stata J (2009) 2.07
The "laboratory" effect: comparing radiologists' performance and variability during prospective clinical and laboratory mammography interpretations. Radiology (2008) 2.06
Opportunistic screening for osteoporosis using abdominal computed tomography scans obtained for other indications. Ann Intern Med (2013) 2.06
Evaluation of procalcitonin, C-reactive protein, interleukin-6 & serum amyloid A as diagnostic biomarkers of bacterial infection in febrile patients. Indian J Med Res (2015) 2.06
Cyclophosphamide and cisplatin compared with paclitaxel and cisplatin in patients with stage III and stage IV ovarian cancer. N Engl J Med (1996) 11.72
Concurrent cisplatin-based radiotherapy and chemotherapy for locally advanced cervical cancer. N Engl J Med (1999) 9.16
Intraperitoneal cisplatin plus intravenous cyclophosphamide versus intravenous cisplatin plus intravenous cyclophosphamide for stage III ovarian cancer. N Engl J Med (1996) 5.56
Overexpression of HER-2/neu is associated with poor survival in advanced epithelial ovarian cancer. Cancer Res (1990) 2.55
Overexpression and mutation of p53 in epithelial ovarian cancer. Cancer Res (1991) 2.20
Comparing risk-adjustment methods for provider profiling. Stat Med (1997) 2.11
Dysmorphologic features of the fetal pelvis in Down syndrome: prenatal sonographic depiction and diagnostic implications of the iliac angle. Radiology (1996) 2.09
Sonographically guided compression repair of pseudoaneurysms: further experience from a single institution. AJR Am J Roentgenol (1999) 2.03
Cost-effectiveness of treatment of early stage endometrial cancer. Gynecol Oncol (1999) 1.99
Breakthrough adverse reactions to low-osmolar contrast media after steroid premedication. AJR Am J Roentgenol (2001) 1.92
A comparison of methods for the estimation of plasma low- and very low-density lipoprotein cholesterol. The Lipid Research Clinics Prevalence Study. JAMA (1986) 1.80
Elevation of multiple serum markers in patients with stage I ovarian cancer. J Natl Cancer Inst (1993) 1.71
Cyclophosphamide and cisplatin versus paclitaxel and cisplatin: a phase III randomized trial in patients with suboptimal stage III/IV ovarian cancer (from the Gynecologic Oncology Group). Semin Oncol (1996) 1.66
Spectrum of mutation and frequency of allelic deletion of the p53 gene in ovarian cancer. J Natl Cancer Inst (1993) 1.60
p53 overexpression in advanced-stage endometrial adenocarcinoma. Am J Obstet Gynecol (1996) 1.59
The prognostic significance of CA 125 half-life in patients with ovarian cancer who have received primary chemotherapy after surgical cytoreduction. Am J Obstet Gynecol (1990) 1.59
Doppler US measurement of portal venous flow: variability in healthy fasting volunteers. Radiology (1997) 1.54
Dynamic helical CT of the abdomen: prospective comparison of pre- and postprandial contrast enhancement. Radiology (1998) 1.53
Evaluation of revised criteria for ventilation-perfusion scintigraphy in patients with suspected pulmonary embolism. Radiology (1994) 1.42
Defining practice patterns in gynecologic oncology to prevent pulmonary embolism and deep venous thrombosis. Gynecol Oncol (2007) 1.36
Epidermal growth factor receptor expression in normal ovarian epithelium and ovarian cancer. I. Correlation of receptor expression with prognostic factors in patients with ovarian cancer. Am J Obstet Gynecol (1991) 1.31
Semiquantitative and visual analysis of FDG-PET images in pulmonary abnormalities. J Nucl Med (1994) 1.30
Renal resistive indexes: variability in Doppler US measurement in a healthy population. Radiology (1996) 1.29
Epidemiologic and surgicopathologic findings of papillary serous and clear cell endometrial cancers when compared to endometrioid carcinoma. Gynecol Oncol (1999) 1.28
The outcome of stage I-II clinically and surgically staged papillary serous and clear cell endometrial cancers when compared with endometrioid carcinoma. Gynecol Oncol (2000) 1.27
Randomized trial of cisplatin versus cisplatin plus mitolactol versus cisplatin plus ifosfamide in advanced squamous carcinoma of the cervix: a Gynecologic Oncology Group study. J Clin Oncol (1997) 1.26
Nonenhanced helical CT and US in the emergency evaluation of patients with renal colic: prospective comparison. Radiology (2000) 1.21
Optimum scanning protocol for FDG-PET evaluation of pulmonary malignancy. J Nucl Med (1995) 1.19
Variability of Doppler US measurements along the common carotid artery: effects on estimates of internal carotid arterial stenosis in patients with angiographically proved disease. Radiology (2000) 1.16
Gestational trophoblastic disease metastatic to the central nervous system. Gynecol Oncol (1995) 1.15
Intracerebral hemorrhage outcome: apolipoprotein E genotype, hematoma, and edema volumes. Neurology (1999) 1.13
Overexpression and mutation of p53 in endometrial carcinoma. Cancer Res (1992) 1.11
Relationship between race and interval to treatment in endometrial cancer. Obstet Gynecol (1995) 1.08
Regulation of growth of normal ovarian epithelial cells and ovarian cancer cell lines by transforming growth factor-beta. Am J Obstet Gynecol (1992) 1.08
Overexpression of HER-2/neu in endometrial cancer is associated with advanced stage disease. Am J Obstet Gynecol (1991) 1.07
Axillary lymph nodes: mammographic, pathologic, and clinical correlation. AJR Am J Roentgenol (1997) 1.07
Pseudoobstruction of the colon complicating choriocarcinoma. Gynecol Oncol (1985) 1.07
The effect of aging on the apparent diffusion coefficient of normal-appearing white matter. AJR Am J Roentgenol (2000) 1.04
The natural history of postoperative venous thromboemboli in gynecologic oncology: a prospective study of 382 patients. Am J Obstet Gynecol (1984) 1.04
5-day methotrexate for women with metastatic gestational trophoblastic disease. Gynecol Oncol (1994) 1.03
An analysis of cell type in patients with surgically staged stage IB carcinoma of the cervix: a Gynecologic Oncology Group study. Gynecol Oncol (1996) 1.03
Evaluation of pseudoenhancement of renal cysts during contrast-enhanced CT. AJR Am J Roentgenol (2000) 1.03
Immunohistochemical expression of CA 125 in endometrial adenocarcinoma: correlation of antigen expression with metastatic potential. Cancer Res (1989) 1.02
Adjuvant radiotherapy following radical hysterectomy for patients with stage IB and IIA cervical cancer. Gynecol Oncol (1990) 1.02
Venous thromboembolism prophylaxis in gynecologic oncology: a prospective, controlled trial of low-dose heparin. Am J Obstet Gynecol (1983) 1.00
Carcinoid metastases to the liver: role of triple-phase helical CT. Radiology (1998) 1.00
Malignant potential of gestational trophoblastic disease at the extreme ages of reproductive life. Obstet Gynecol (1984) 0.97
Diagnosis of pancreatic carcinoma: role of FDG PET. AJR Am J Roentgenol (1998) 0.97
Abdominal percutaneous interventional procedures: comparison of CT and US guidance. Radiology (1998) 0.96
Epidermal growth factor receptor expression in normal ovarian epithelium and ovarian cancer. II. Relationship between receptor expression and response to epidermal growth factor. Am J Obstet Gynecol (1991) 0.96
Thromboembolism complicating surgery for cervical and uterine malignancy: incidence, risk factors, and prophylaxis. Obstet Gynecol (1983) 0.95
Expression of epidermal growth factor receptor and HER-2/neu in normal and neoplastic cervix, vulva, and vagina. Obstet Gynecol (1990) 0.95
Postsurgical surveillance of patients with FIGO stage I/II endometrial adenocarcinoma. Gynecol Oncol (1995) 0.94
Mutation of the p53 tumor-suppressor gene is not a feature of endometrial hyperplasias. Am J Obstet Gynecol (1993) 0.94
Comparison of gracilis and rectus abdominis myocutaneous flap neovaginal reconstruction performed during radical pelvic surgery: flap-specific morbidity. Int J Gynecol Cancer (2007) 0.93
Improved palliation of cerebral metastases in epithelial ovarian cancer using a combined modality approach including radiation therapy, chemotherapy, and surgery. J Clin Oncol (1992) 0.92
Surgical management of intestinal obstruction in ovarian cancer. I. Clinical features, postoperative complications, and survival. Gynecol Oncol (1987) 0.92
Multivariable analysis of DNA ploidy, p53, and HER-2/neu as prognostic factors in endometrial cancer. Cancer (1994) 0.92
Overexpression of p53 is not a feature of benign and early-stage borderline epithelial ovarian tumors. Gynecol Oncol (1994) 0.92
Optimizing contrast-enhanced abdominal CT in infants and children using bolus tracking. AJR Am J Roentgenol (1999) 0.92
Preoperative evaluation of serum CA 125, TAG 72, and CA 15-3 in patients with endometrial carcinoma. Am J Obstet Gynecol (1990) 0.91
Racial disparity in overexpression of the p53 tumor suppressor gene in stage I endometrial cancer. Am J Obstet Gynecol (1997) 0.90
Short gracilis myocutaneous flaps for vulvovaginal reconstruction after radical pelvic surgery. Obstet Gynecol (1989) 0.89
Management of stage IA carcinoma of the cervix. Am J Obstet Gynecol (1985) 0.89
Alternating weekly chemotherapy with etoposide-methotrexate-dactinomycin/cyclophosphamide-vincristine for high-risk gestational trophoblastic disease. Obstet Gynecol (1994) 0.89
Renal metastases of gestational trophoblastic disease: a report of eight cases. Obstet Gynecol (1988) 0.88
Pelvic exenteration: factors associated with major surgical morbidity. Gynecol Oncol (1989) 0.88
Estrogen replacement therapy in the patient treated for endometrial cancer. Obstet Gynecol (1986) 0.87
The failure of aerosolized superoxide dismutase to modify pulmonary oxygen toxicity. Am Rev Respir Dis (1977) 0.87
Necrotizing fasciitis in irradiated tissue from diabetic women. A report of two cases. J Reprod Med (1991) 0.87
Influence of cytoplasmic steroid receptor content on prognosis of early stage endometrial carcinoma. Am J Obstet Gynecol (1985) 0.87
High-risk gestational trophoblastic neoplasia with brain metastases: individualized multidisciplinary therapy in the management of four patients. Gynecol Oncol (2006) 0.86
Prevention of postoperative venous thromboembolism by external pneumatic calf compression in patients with gynecologic malignancy. Obstet Gynecol (1984) 0.86
Comparison of sonographic and CT guidance techniques: does CT fluoroscopy decrease procedure time? AJR Am J Roentgenol (2000) 0.86
Alterations of occlusive cuff impedance plethysmography results in the obstetric patient. Surgery (1981) 0.85
Prevention of superficial wound separation with subcutaneous retention sutures. Gynecol Oncol (1993) 0.85
Sonographic estimates of vein size in the lower extremities: subjective assessment compared with direct measurement. J Clin Ultrasound (1998) 0.85
Superior vena cava syndrome associated with gynecologic malignancy. Gynecol Oncol (1986) 0.85
Comparison of unenhanced, hepatic arterial-dominant, and portal venous-dominant phase helical CT for the detection of liver metastases in women with breast carcinoma. AJR Am J Roentgenol (1999) 0.85
Recurrent gestational trophoblastic disease. Experience of the Southeastern Regional Trophoblastic Disease Center. Cancer (1990) 0.84
A comparison of symptomatology, physical examination, and vaginal cytology in the detection of recurrent cervical carcinoma after radical hysterectomy. Obstet Gynecol (1990) 0.84
Doppler evaluation of renal artery stenosis: interobserver agreement in the interpretation of waveform morphology. AJR Am J Roentgenol (1994) 0.84
OVX1 radioimmunoassay complements CA-125 for predicting the presence of residual ovarian carcinoma at second-look surgical surveillance procedures. J Clin Oncol (1993) 0.84
Cytoplasmic estrogen and progesterone receptor content of uterine sarcomas. Am J Obstet Gynecol (1984) 0.84
Vascular plasminogen activator levels and thromboembolic disease in patients with gynecologic malignancies. Am J Obstet Gynecol (1984) 0.84
Sonographic assessment of lower limb vein diameters: implications for the diagnosis and characterization of deep venous thrombosis. AJR Am J Roentgenol (1997) 0.84
Phase I/II trial of intravenous Doxil and whole abdomen hyperthermia in patients with refractory ovarian cancer. Int J Hyperthermia (2005) 0.83
The negative prognostic implications of thrombocytosis in women with stage IB cervical cancer. Obstet Gynecol (1994) 0.82
Rectus abdominis myocutaneous flaps for neovaginal reconstruction after radical pelvic surgery. Int J Gynecol Cancer (2005) 0.82
Computed tomography in evaluation of patients with ovarian carcinoma in complete clinical remission. Correlation with surgical-pathologic findings. JAMA (1986) 0.82
Long-term effects on bladder function following radical hysterectomy with and without postoperative radiation. Gynecol Oncol (1987) 0.82
Variables associated with postoperative deep venous thrombosis: a prospective study of 411 gynecology patients and creation of a prognostic model. Obstet Gynecol (1987) 0.82
Role of computed axial tomography of the chest in staging patients with nonmetastatic gestational trophoblastic disease. Obstet Gynecol (1986) 0.82
Doppler sonography of the portal vein and hepatic artery: measurement of a prandial effect in healthy subjects. Radiology (1998) 0.82
The anterior iliac separation: alternative index for pelvic morphometry in fetuses with Down syndrome. AJR Am J Roentgenol (2001) 0.81
Early systole in the healthy kidney: variability of Doppler US waveform parameters. Radiology (1997) 0.81
Long and short gracilis myocutaneous flaps for vulvovaginal reconstruction after radical pelvic surgery: comparison of flap-specific complications. Gynecol Oncol (1995) 0.81
Perioperative external pneumatic calf compression as thromboembolism prophylaxis in gynecologic oncology: report of a randomized controlled trial. Gynecol Oncol (1984) 0.81
Helical liver CT with computer-assisted bolus-tracking technology: is it possible to predict which patients will not achieve a threshold of enhancement? Radiology (1998) 0.81